Ghiasvand R(2026) High-Risk Stage II Melanoma: AJCC Staging anomaly or understaging dilemma? Br J Dermatol(in press) DOI 10.1093/bjd/ljaf523, PubMed 41483011
Sjøen GH, Hauge TH, Falk RS, Tønnessen TI, Langesæter E(2026) Haemodynamic Changes After Prophylactic Doses of Ephedrine, Phenylephrine, Norepinephrine Versus Placebo During Induction of General Anaesthesia: A Randomised Trial Acta Anaesthesiol Scand, 70(1), e70138 DOI 10.1111/aas.70138, PubMed 41144827
Amdal CD, Falk RS, Alanya A, Schlichting M, Roychoudhury S, Bhatnagar V, Wintner LM, Regnault A, Ingelgård A, Coens C, le Cessie S, Holzner B, Chang J, Taphoorn M, Cislo P, Giesinger JM, Cappelleri JC, Pawar V, Ten Seldam S, Papadopoulos EJ, Calvert MJ, Joseph KL, Bottomley A, Griebsch I, Arraras JIet al.(2025) SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials Lancet Oncol, 26(12), e683-e693 DOI 10.1016/S1470-2045(25)00520-0, PubMed 41308689
